RxDoctor Payments Data

Katie Meador

Acute Care · Chicago, ILNPI 1255754040

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 274 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Acera Surgical, Inc. at 34.6% of the total. 2025 is the largest year on record at $2,908, 2.8 times the $1,035 reported in 2021. Among acute care clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,962in general payments, 2019–2025

Across 274 payments — averaging $36.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$3K
  • Kerecis Limited$3K
  • Mimedx Group, Inc.$899
  • Organogenesis Inc.$780
  • Smith+Nephew$522
  • Urgo Medical North America, LLC$273
  • plus $701 from 7 others
$8,034in research payments, 2019–2025

Across 1 payment — averaging $8034.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acera Surgical, Inc.$8K

What the payments were for

  • Food & beverage$9,962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acera Surgical, Inc.147$3,446
Kerecis Limited39$3,342
Mimedx Group, Inc.19$899
Organogenesis Inc.22$780
Smith+Nephew18$522
Urgo Medical North America, LLC5$273
Reapplix Inc.15$265
Biowound Solutions, Inc.2$149
Polynovo North America LLC1$123
Omeza LLC2$86
Convatec Inc.2$34
Solventum Corporation1$29
Currax Pharmaceuticals LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,962 in reported general payments places this provider in the 95th percentile of 461 acute care providers in Illinois.

See all acute care providers in Illinois

Medicare billing

Part B allowed, 2024
$59,203
Medicare patients
116
Services billed
1,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate20$341
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$109

Paid to pharmacies, not to this prescriber.

Other acute care in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →